Manabu Akazawa
Overview
Explore the profile of Manabu Akazawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
550
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shoji T, Muto R, Sakai R, Matsumura H, Uchida T, Kitta F, et al.
AIMS Microbiol
. 2023 Jan;
8(4):528-543.
PMID: 36694583
This retrospective, observational cohort study investigated the economic impact of genotype by classifying methicillin-resistant (MRSA) by using the polymerase chain reaction-based open reading frame typing (POT) method. Using administrative claims...
12.
Ishikawa T, Nishigori H, Akazawa M, Miyakoda K, Noda A, Ishikuro M, et al.
Pregnancy Hypertens
. 2023 Jan;
31:73-83.
PMID: 36646019
Objectives: To evaluate the major congenital malformation (MCM) risk of first-trimester antihypertensive exposure, specifically of amlodipine and methyldopa. Study Design: A large administrative claims database was used. Main Outcome Measures:...
13.
Takumoto Y, Sasahara Y, Narimatsu H, Murata T, Akazawa M
Health Econ Rev
. 2023 Jan;
13(1):3.
PMID: 36629978
No abstract available.
14.
Yasu T, Sakurai K, Hoshino M, Akazawa M
Leuk Lymphoma
. 2022 Dec;
64(3):730-733.
PMID: 36576099
No abstract available.
15.
Takumoto Y, Sasahara Y, Narimatsu H, Murata T, Akazawa M
Health Econ Rev
. 2022 Dec;
12(1):63.
PMID: 36564539
Backgrounds: Limited information is available on the utility values of metastatic pancreatic cancer, focusing on different health statuses, selected chemotherapy, and related grades 1/2 and 3/4 adverse events (AEs). We...
16.
Kobayashi S, Yasu T, Akazawa M
Curr Oncol
. 2022 Dec;
29(12):9826-9832.
PMID: 36547186
Management of tumor lysis syndrome (TLS) associated with cancer chemotherapy for malignant tumors is important because of its potentially fatal course. The use of rasburicase, a recombinant urate oxidase, is...
17.
Shoji T, Muto R, Fukuda H, Muraki Y, Kawata K, Akazawa M
Antimicrob Steward Healthc Epidemiol
. 2022 Dec;
2(1):e147.
PMID: 36483379
Objective: To compare the incremental costs and healthcare utilization of methicillin-resistant (MRSA) bacteremia with those of methicillin-susceptible (MSSA) bacteremia. Design: Retrospective cohort study using data from April 2014 to March...
18.
Murakami S, Takamatsu A, Akazawa M, Goto T, Miwa T, Terayama Y, et al.
Antimicrob Steward Healthc Epidemiol
. 2022 Dec;
2(1):e53.
PMID: 36483370
Antimicrobial use during the coronavirus disease 2019 (COVID-19) pandemic at a tertiary-care center was analyzed using interrupted time-series analysis. Among intravenous antimicrobials, the use of azithromycin and third-generation cephalosporins significantly...
19.
Akazawa M, Shima D, Sato T, Shoji E, LoPresti M, Nishi R
Patient Prefer Adherence
. 2022 Nov;
16:3081-3094.
PMID: 36387049
Background: Poor adherence to daily human growth hormone (hGH) treatment has been shown to be associated with poor clinical outcomes for growth hormone deficiency (GHD) patients. However, few studies have...
20.
Yasu T, Sakurai K, Akazawa M
Curr Oncol
. 2022 May;
29(5):3242-3251.
PMID: 35621654
Invasive fungal disease (IFD) is an important cause of morbidity and mortality in patients with hematological malignancies. As chronic lymphocytic leukemia (CLL) is a rare hematological malignancy in Japan, IFD...